Skip to main content
Log In
Sign Up
Home
Stocks
Stock Screener
Stock Exchanges
Comparison Tool
Earnings Calendar
By Industry
Stock Lists
Top Analysts
Top Stocks
Corporate Actions
IPOs
Recent IPOs
IPO Calendar
IPO Statistics
IPO News
IPO Screener
ETFs
ETF Screener
Comparison Tool
New Launches
ETF Providers
News
Trending
Articles
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After Hours
Market Heatmap
Market Newsletter
Stock Analysis Pro
Watchlist
Collapse
Home
»
Analysts
»
James Condulis
James Condulis
Stock Analyst at Stifel
(0.48)
# 3,923
Out of 4,761 analysts
2
Total ratings
n/a
Success rate
-1.86%
Average return
Main Sectors:
Healthcare
Top Industries:
Biotechnology
Stocks Rated by James Condulis
Stock
Action
Price Target
Current
Upside
Ratings
Updated
CYTK
Cytokinetics
Initiates:
Buy
$80
$50.26
+59.17%
1
Jan 22, 2025
EWTX
Edgewise Therapeutics
Initiates:
Hold
$30
$27.07
+10.82%
1
Jan 22, 2025
CYTK
Cytokinetics
Jan 22, 2025
Initiates:
Buy
Price Target:
$80
Current: $50.26
Upside:
+59.17%
1 Ratings
View All
EWTX
Edgewise Therapeutics
Jan 22, 2025
Initiates:
Hold
Price Target:
$30
Current: $27.07
Upside:
+10.82%
1 Ratings
View All